Biopharmaceutical company Seaport Therapeutics announced the appointment of Lana Gladstein as general counsel.

Most recently, Gladstein was the group general counsel at APRINOIA Therapeutics. Her prior roles include chief legal officer at Recipharm; chief legal officer and general counsel at Arranta Bio; and executive vice president, general counsel, and officer at Brammer Bio.